http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2132200-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d709e3167fa2f99a1803c9cfeb0aca63 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D285-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D285-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D285-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04 |
| filingDate | 1983-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4faad5b889ad04099a26e000349acbc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89252cd215bb4cd75e7a360e18427970 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4eb17673d014ba82ff29ac02d6f6e00c |
| publicationDate | 1984-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-2132200-A |
| titleOfInvention | Carboxamido-derivatives of 5H-1,3,4-thiadiazolo[3,2-a]-pyrimidines and process for their preparation |
| abstract | Novel compounds of general formula (I> <IMAGE> wherein R1 represents: (a) hydrogen, halogen or C1-C6 alkyl unsubstituted or substituted by C1-C6 alkoxy; (b> <IMAGE> wherein n is zero, 1, 2 or 3 and each of R4 and R5 is, independently, hydrogen or C1-C6 alkyl, or R4 and R5, taken together with the nitrogen atom to which they are linked, form an unsubstituted N- pyrrolidinyl ring or a piperidino, morpholino, N-piperazinyl or <IMAGE> ring, wherein m is zero, 1 or 2, the piperidino and morpholino rings are unsubstituted or substituted by one or two C1-C6 alkyl groups and the N-piperazinyl ring is unsubstituted or substituted by a substituent chosen from C1-C6 alkyl, phenyl and pyridyl; (c) trihalomethyl or R6-S(O)p-, wherein p is zero, 1 or 2 and R6 is C1-C6 alkyl or benzyl, wherein the phenyl ring is unsubstituted or substituted by a substituent chosen from halogen, C1-C6 alkyl and C1-C6 alkoxy; or (d) an unsubstituted pyridyl, pyridyl-N-oxide or thienyl ring or a phenyl ring unsubstituted or substituted by one, two or three substituents independently chosen from halogen, C1-C6 alkyl, C1-C6 alkoxy, hydroxy, formyloxy, C2-C8 alkanoyloxy, nitro, amino, formylamino, C2-C8 alkanoylamino and di-(C1-C6) alkylamino; R2 represents hydrogen or C1-C6 alkyl; R3 represents: (a') phenyl unsubstituted or substituted by one or two substituents independently chosen from C1-C6 alkyl, C1-C6 alkoxy and halogen; (b') an unsaturated heteromonocyclic or heterobicyclic ring, containing one or more heteroatoms chosen from nitrogen and sulphur, unsubstituted or substituted by one or two substituents independently chosen from halogen, C1-C6 alkyl and C1-C6 alkoxy; and the pharmaceutically acceptable salts thereof; are useful as anti-inflammatory and analgesic agents. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4548938-A |
| priorityDate | 1982-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 103.